相似文献
1
Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.
Antioxid Redox Signal. 2011 Jul 15;15(2):505-21. doi: 10.1089/ars.2010.3790. Epub 2011 Apr 26.
2
Endoplasmic reticulum stress in nonalcoholic fatty liver disease.
Annu Rev Nutr. 2012 Aug 21;32:17-33. doi: 10.1146/annurev-nutr-071811-150644.
3
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.
World J Gastroenterol. 2014 Feb 21;20(7):1768-76. doi: 10.3748/wjg.v20.i7.1768.
4
The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
Toxicol Sci. 2014 Jan;137(1):26-35. doi: 10.1093/toxsci/kft230. Epub 2013 Oct 4.
5
Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.
Free Radic Res. 2015;49(12):1405-18. doi: 10.3109/10715762.2015.1078461. Epub 2015 Aug 25.
6
Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease.
Biofactors. 2011 Jan-Feb;37(1):8-16. doi: 10.1002/biof.135. Epub 2010 Dec 2.
7
The unfolded protein response in fatty liver disease.
Semin Liver Dis. 2013 Nov;33(4):321-9. doi: 10.1055/s-0033-1358522. Epub 2013 Nov 12.
8
Endoplasmic reticulum proteostasis in hepatic steatosis.
Nat Rev Endocrinol. 2016 Dec;12(12):710-722. doi: 10.1038/nrendo.2016.124. Epub 2016 Aug 12.
9
Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.
Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C279-90. doi: 10.1152/ajpcell.00117.2013. Epub 2013 Nov 27.
10
Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD).
Curr Drug Targets. 2018;19(9):1087-1094. doi: 10.2174/1389450118666180516122517.
引用本文的文献
1
Effects of Grape By-Products on Oxidative Stress and Inflammation in Farm Animals: An Overview of Studies Performed in Pigs, Chickens, and Cattle.
Animals (Basel). 2025 May 23;15(11):1536. doi: 10.3390/ani15111536.
2
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances.
Front Oncol. 2025 Apr 8;15:1526206. doi: 10.3389/fonc.2025.1526206. eCollection 2025.
3
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD.
Biomedicines. 2025 Feb 6;13(2):393. doi: 10.3390/biomedicines13020393.
4
polysaccharides alleviate metabolic dysfunction-associated steatotic liver disease through enhancing hepatocyte RelA/ HNF1α signaling.
World J Gastroenterol. 2025 Jan 28;31(4):93179. doi: 10.3748/wjg.v31.i4.93179.
5
A Comprehensive Review on Non-Alcoholic Fatty Liver Disease.
Cureus. 2023 Dec 8;15(12):e50159. doi: 10.7759/cureus.50159. eCollection 2023 Dec.
6
Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised "Two-Hit" Hypothesis.
Cells. 2023 May 20;12(10):1434. doi: 10.3390/cells12101434.
7
DHA induces adipocyte lipolysis through endoplasmic reticulum stress and the cAMP/PKA signaling pathway in grass carp ().
Anim Nutr. 2022 Dec 31;13:185-196. doi: 10.1016/j.aninu.2022.10.010. eCollection 2023 Jun.
8
Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis.
Cells. 2023 Apr 1;12(7):1069. doi: 10.3390/cells12071069.
9
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.
Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.
10
GRP78 Activity Moderation as a Therapeutic Treatment against Obesity.
Int J Environ Res Public Health. 2022 Nov 30;19(23):15965. doi: 10.3390/ijerph192315965.
本文引用的文献
1
Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.
Obes Surg. 2010 Dec;20(12):1698-709. doi: 10.1007/s11695-010-0171-6.
2
Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1.
Mol Cell. 2010 Apr 23;38(2):291-304. doi: 10.1016/j.molcel.2010.04.001.
3
Distinct gene expression profiles characterize cellular responses to palmitate and oleate.
J Lipid Res. 2010 Aug;51(8):2121-31. doi: 10.1194/jlr.M004275. Epub 2010 Apr 20.
4
Insulin resistance in nonalcoholic fatty liver disease.
Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875.
5
The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation.
Nat Med. 2010 Apr;16(4):429-37. doi: 10.1038/nm.2099. Epub 2010 Mar 28.
6
A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response.
Nat Med. 2010 Apr;16(4):438-45. doi: 10.1038/nm.2121. Epub 2010 Mar 28.
7
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
Cell. 2010 Mar 19;140(6):900-17. doi: 10.1016/j.cell.2010.02.034.
8
Rapamycin inhibits postprandial-mediated X-box-binding protein-1 splicing in rat liver.
J Nutr. 2010 May;140(5):879-84. doi: 10.3945/jn.109.119883. Epub 2010 Mar 17.
9
Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death.
Am J Physiol Endocrinol Metab. 2010 May;298(5):E1027-35. doi: 10.1152/ajpendo.00642.2009. Epub 2010 Feb 16.
10
Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.
Cell. 2010 Feb 5;140(3):338-48. doi: 10.1016/j.cell.2010.01.001.
Zotero 插件